Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

C1Q COMPONENT COMPLEMENT - ANVISA Registration 81148560020

Access comprehensive regulatory information for C1Q COMPONENT COMPLEMENT in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81148560020 and manufactured by EUROIMMUN AG. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 3 companies making the same product including THE BINDING SITE GROUP LTD, ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
5 Recent Registrations
81148560020
Registration Details
ANVISA Registration Number: 81148560020
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Imunocomplexos circulantes (CIC-C1q) IgG
Risk Class II

Registration Details

81148560020

25351053605201635

93741726000166

Company Information

EUROIMMUN AG
Germany
PT: ALEMANHA

Dates and Status

Jul 25, 2016

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "C1Q COMPONENT COMPLEMENT"